107 related articles for article (PubMed ID: 3501474)
1. Mitogenic response and interleukin 2 production in Crohn's disease.
Miura M; Hiwatashi N
J Clin Lab Immunol; 1987 Nov; 24(3):113-6. PubMed ID: 3501474
[TBL] [Abstract][Full Text] [Related]
2. Role of prostaglandins on lymphocyte transformation in Crohn's disease.
Echevarría S; Cajigas J; Rodríguez de Lope C; Lozano JL; Pons Romero F
Allergol Immunopathol (Madr); 1989; 17(6):317-21. PubMed ID: 2635833
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism.
Santoli D; Zurier RB
J Immunol; 1989 Aug; 143(4):1303-9. PubMed ID: 2545787
[TBL] [Abstract][Full Text] [Related]
4. Cytokine production in inflammatory bowel disease.
Miura M; Hiwatashi N
J Clin Lab Immunol; 1985 Oct; 18(2):81-6. PubMed ID: 3908685
[TBL] [Abstract][Full Text] [Related]
5. Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease.
Goodacre RL; Bienenstock J
Gastroenterology; 1982 Apr; 82(4):653-8. PubMed ID: 7060886
[TBL] [Abstract][Full Text] [Related]
6. 1,25-dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn's disease.
Bartels LE; Jørgensen SP; Agnholt J; Kelsen J; Hvas CL; Dahlerup JF
Int Immunopharmacol; 2007 Dec; 7(13):1755-64. PubMed ID: 17996686
[TBL] [Abstract][Full Text] [Related]
7. In vitro inhibition of interleukin-2 production by peripheral blood lymphocytes from stage III melanoma patients by prostaglandin E2: enhancement of lymphocyte proliferation by exogenous interleukin-2 plus indomethacin.
Murray JL; Dowd J; Hersh EM
J Biol Response Mod; 1986 Feb; 5(1):12-9. PubMed ID: 3485703
[TBL] [Abstract][Full Text] [Related]
8. Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness.
Victorino RM
J Clin Lab Immunol; 1983 Aug; 11(4):197-201. PubMed ID: 6230454
[TBL] [Abstract][Full Text] [Related]
9. [Natural killer (NK) cells and interleukin 2 (IL-2) in Crohn disease].
Lozano Polo JL; Echevarría Vierna S; Casafont Morencos F; Ledesma Castaño F; Pons Romero F
Rev Esp Enferm Dig; 1990 Aug; 78(2):71-5. PubMed ID: 2271297
[TBL] [Abstract][Full Text] [Related]
10. Depressed PMNC blastogenic response in patients with cancer of the head and neck: a study of IL-2 production, IL-2 consumption, and IL-2 receptor expression.
Eskinazi DP; Perna JJ; Ershow AG; Mihail RC
Laryngoscope; 1989 Feb; 99(2):151-7. PubMed ID: 2783615
[TBL] [Abstract][Full Text] [Related]
11. Induction of impaired activation of lymphocytes by suppressive factor in Crohn's disease patients.
Watanabe M; Tsuru S; Aiso S; Hibi T; Yoshida T; Asakura H; Zinnaka Y; Tsuchiya M
J Clin Lab Immunol; 1984 May; 14(1):29-34. PubMed ID: 6748044
[TBL] [Abstract][Full Text] [Related]
12. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis.
Kirman I; Nielsen OH
Am J Gastroenterol; 1996 Sep; 91(9):1789-94. PubMed ID: 8792700
[TBL] [Abstract][Full Text] [Related]
13. In vitro effect of indomethacin on mitogen-induced lymphoproliferative response in lung cancer patients.
Stanojević-Bakić N; Vucković-Dekić L; Susnjar S; Spuzić I
Neoplasma; 1992; 39(2):129-32. PubMed ID: 1326720
[TBL] [Abstract][Full Text] [Related]
14. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
15. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
Braun DP; Harris JE
J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
[TBL] [Abstract][Full Text] [Related]
16. Crohn's disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria.
Hvas CL; Kelsen J; Agnholt J; Höllsberg P; Tvede M; Møller JK; Dahlerup JF
Scand J Gastroenterol; 2007 May; 42(5):592-601. PubMed ID: 17454880
[TBL] [Abstract][Full Text] [Related]
17. Linoleic acid induces interleukin-8 production by Crohn's human intestinal smooth muscle cells via arachidonic acid metabolites.
Alzoghaibi MA; Walsh SW; Willey A; Yager DR; Fowler AA; Graham MF
Am J Physiol Gastrointest Liver Physiol; 2004 Apr; 286(4):G528-37. PubMed ID: 14656710
[TBL] [Abstract][Full Text] [Related]
18. Indomethacin enhancement of immunocompetence in melanoma patients.
Tilden AB; Balch CM
Surgery; 1981 Jul; 90(1):77-84. PubMed ID: 6972628
[TBL] [Abstract][Full Text] [Related]
19. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
Auer IO; Röder A; Fröhlich J
Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
[TBL] [Abstract][Full Text] [Related]
20. Bioactive IL-18 expression is up-regulated in Crohn's disease.
Monteleone G; Trapasso F; Parrello T; Biancone L; Stella A; Iuliano R; Luzza F; Fusco A; Pallone F
J Immunol; 1999 Jul; 163(1):143-7. PubMed ID: 10384110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
